NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

脊柱植入物/手術器械市場:全球行業趨勢/佔有率/市場規模/增長/機會/預測(2020-2025)

Spinal Implants and Surgery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

出版商 IMARC Services Private Limited 商品編碼 960501
出版日期 內容資訊 英文 106 Pages
商品交期: 2-3個工作天內
價格
脊柱植入物/手術器械市場:全球行業趨勢/佔有率/市場規模/增長/機會/預測(2020-2025) Spinal Implants and Surgery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025
出版日期: 2020年09月03日內容資訊: 英文 106 Pages
簡介

在2014年至2019年期間,全球脊柱植入物和手術器械市場的複合年增長率約為6%。

諸如退行性椎間盤疾病,後凸畸形,後凸畸形和脊椎滑脫等脊柱疾病的流行是市場增長的主要驅動力之一。這可能是由於大多數工人久坐不動的生活方式和繁忙的工作日程,進而導致肥胖,下腰痛,姿勢相關的問題以及其他脊柱退行性疾病。速度大大提高。

另外,專為尚未達到骨骼成熟的患者(尤其是兒童)而設計的有效的生長保持裝置的開發,也為市場的增長做出了貢獻。此外,各種技術進步,例如先進的骨移植產品的開發以及比金屬更耐用的材料的使用,正在支持市場的增長。預計其他因素,例如老年人口的增長和微創脊柱外科手術的廣泛採用,將進一步推動市場。展望未來,預計全球脊柱植入物和手術器械市場在未來五年將繼續溫和增長。

該報告調查了全球脊柱植入物和手術器械市場,並提供了系統信息,例如市場概況,按細分市場和地區劃分的市場規模預測,主要公司的概況以及競爭條件的分析。

目錄

第1章序言

第2章範圍和調查方法

第3章執行摘要

第4章簡介

第5章全球脊柱植入物/手術設備市場

  • 市場概況
  • 市場表現
  • COVID-19的影響

第6章市場細分:按產品

  • 胸部固定/腰(脊椎)固定裝置
  • 頸椎融合器
  • 脊柱生物製劑
  • 脊柱壓縮性骨折(VCF)治療裝置
  • 脊柱減壓裝置
  • 非固定裝置
  • 脊骨刺激器

第7章市場細分:按手術類型

  • 開血手術
  • 微創手術

第8章市場細分:按最終用戶

  • 醫院
  • 門診外科診所(ASC)
  • 其他

第9章市場細分:按地區

  • 北美
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳大利亞
    • 印度尼西亞
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場細分:按國家

第10章SWOT分析

第11章價值鏈分析

第12章波特的五力分析

第13章價格分析

第14章競爭情況

  • 市場結構
  • 主要公司
  • 主要公司簡介
    • Abbott Laboratories
    • B. Braun (B. Braun Holding GmbH & Co. KG)
    • Boston Scientific
    • Depuy Synthes (Johnson & Johnson)
    • Exactech Inc. (Choice Spine)
    • Globus Medical Inc.
    • Integra LifeSciences Holdings Corporation
    • Medtronic Plc
    • Nuvasive Inc. (Smith & Nephew Plc)
    • Orthofix Medical Inc.
    • RTI Surgical Inc.
    • Stryker Corporation
    • Zimmer Biomet Holdings Inc.
目錄
Product Code: SR1019M47_Report

The global spinal implants and surgery devices market grew at a CAGR of around 6% during 2014-2019. Spinal implants and surgery devices refer to the medical equipment used to treat spinal deformities and disorders. These implants are manufactured using biocompatible materials, such as titanium, titanium-alloy and stainless-steel, and are commonly available in two variants, namely fusion and non-fusion implants. Fusion implants include rods, plates, screws and interbody cages. On the other hand, non-fusion implants include artificial discs, expandable rods and growth sparing devices. Apart from this, thoracic, lumbar and cervical fusion and spinal decompression devices are also used for various treatment procedures. These implants are used to facilitate the movement of two vertebrae, improve the stability of the spine and correct deformities.

The increasing prevalence of spinal disorders, such as degenerative disc disease, scoliosis, kyphosis and spondylolisthesis, is one of the key factors driving the growth of the market. This can be attributed to the sedentary lifestyles and hectic schedules of the majority of the working population, which, in turn, is significantly increasing the incidences of obesity, back pain, posture-related problems and other degenerative spinal conditions. Furthermore, the development of efficient growth-sparing devices, which are specifically designed for patients, especially children, who have not reached skeletal maturity is also contributing to the market growth. Additionally, various technological advancements, such as the development of advanced bone grafting products and the utilization of materials that are more durable than metal, are favoring the growth of the market. Other factors, including the rising geriatric population and widespread adoption of minimally invasive (MI) spinal surgeries, are expected to drive the market further. Looking forward, IMARC Group expects the global spinal implants and surgery devices market to continue its moderate growth during the next five years.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global spinal implants and surgery devices market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, product, type of surgery and end user.

Breakup by Product:

  • Thoracic Fusion and Lumbar Fusion Devices
  • Cervical Fusion Devices
  • Spine Biologics
  • Vertebral Compression Fracture Treatment Devices
  • Spinal Decompression Devices
  • Non-Fusion Devices
  • Spine Bone Stimulators

Breakup by Type of Surgery:

  • Open Surgeries
  • Minimally Invasive Surgeries

Breakup by End User:

  • Hospitals
  • Ambulatory Surgery Centers
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, B. Braun (B. Braun Holding GmbH & Co. KG), Boston Scientific, Depuy Synthes (Johnson & Johnson), Exactech Inc. (Choice Spine), Globus Medical Inc., Integra LifeSciences Holdings Corporation, Medtronic Plc, Nuvasive Inc. (Smith & Nephew Plc), Orthofix Medical Inc., RTI Surgical Inc., Stryker Corporation and Zimmer Biomet Holdings Inc.

Key Questions Answered in This Report:

  • How has the global spinal implants and surgery devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global spinal implants and surgery devices market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the type of surgery?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global spinal implants and surgery devices market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Spinal Implants and Surgery Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Thoracic Fusion and Lumbar Fusion Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Cervical Fusion Devices
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Spine Biologics
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Vertebral Compression Fracture Treatment Devices
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Spinal Decompression Devices
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Non-Fusion Devices
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Spine Bone Stimulators
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Type of Surgery

  • 7.1 Open Surgeries
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Minimally Invasive Surgeries
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgery Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 B. Braun (B. Braun Holding GmbH & Co. KG)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Boston Scientific
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Depuy Synthes (Johnson & Johnson)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Exactech Inc. (Choice Spine)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Globus Medical Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Integra LifeSciences Holdings Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medtronic Plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Nuvasive Inc. (Smith & Nephew Plc)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Orthofix Medical Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 RTI Surgical Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Stryker Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Zimmer Biomet Holdings Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis